Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
55.60
+1.90 (3.54%)
At close: May 22, 2026

STO:IBT.B Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Revenue
--00.080.01-
--00.080.01-
Revenue Growth (YoY)
---94.80%541.67%--
Gross Profit
--00.080.01-
Selling, General & Admin
19.820.1519.313.511.021.12
Research & Development
55.248.85126.05121.1864.843.56
Operating Expenses
7569145.35134.6965.8244.67
Operating Income
-75-69-145.34-134.62-65.81-44.67
Interest Expense
-----0.29-0.41
Interest & Investment Income
567.073.838.4411.550.65-
Other Non Operating Income (Expenses)
-563.44----0.09
Pretax Income
-71.36-65.17-136.91-123.07-65.45-44.99
Net Income
-71.36-65.17-136.91-123.07-65.45-44.99
Net Income to Common
-71.36-65.17-136.91-123.07-65.45-44.99
Shares Outstanding (Basic)
131313121111
Shares Outstanding (Diluted)
131313121111
Shares Change (YoY)
--8.95%10.14%--
EPS (Basic)
-5.30-4.84-10.16-9.95-5.83-4.01
EPS (Diluted)
-5.30-4.84-10.16-9.95-5.83-4.01
Free Cash Flow
-56.78-72.34-113.13-101.22-85.8-55.62
Free Cash Flow Per Share
-4.21-5.37-8.40-8.19-7.64-4.96
Gross Margin
--100.00%100.00%100.00%-
Operating Margin
---3633575.00%-174827.27%-548400.00%-
Profit Margin
---3422625.00%-159828.57%-545425.00%-
Free Cash Flow Margin
---2828325.00%-131453.25%-714958.33%-
EBIT
-75-69-145.34-134.62-65.81-44.67
Source: S&P Global Market Intelligence. Standard template. Financial Sources.